FOXO4-DRI (10mg)

FOXO4-DRI (10mg) Research Peptide

Product Overview

FOXO4-DRI is a peptide designed to disrupt the interaction between FOXO4 and p53, promoting apoptosis in senescent cells. Supplied in a 10mg vial, it is utilized in aging research to study cellular senescence and potential anti-aging interventions.

Key Features

• Senolytic Research: Ideal for studies on eliminating senescent cells.
• Aging Studies: Exploring interventions to extend healthspan.
• High Purity: Purity over 98% confirmed by HPLC.
• Lyophilized Powder: Ensures stability and ease of handling.

Specifications

• Molecular Formula: [Specific formula if available]
• Molecular Weight: Approximately 2188.5 g/mol
• Appearance: White lyophilized powder
• Quantity: 10mg per vial
• Purity: >98% (HPLC)
• Solubility: Soluble in DMSO or sterile water
• Storage Conditions: Store at -20°C, protected from light

Potential Research Applications

• Cellular Senescence: Studying mechanisms of aging at the cellular level.
• Cancer Research: Exploring pathways involved in cell cycle regulation.
• Apoptosis Studies: Investigating programmed cell death mechanisms.
• Regenerative Medicine: Understanding how to promote healthy cell turnover.

Handling and Storage

• Reconstitution: Dissolve in DMSO or suitable solvent.
• Storage After Reconstitution: Store at -20°C and use within recommended time.
• Stability Considerations: Minimize exposure to air and light.

Safety and Compliance

• Research Use Only: Not intended for human or veterinary use.
• Laboratory Safety: Use appropriate PPE and follow safety protocols.
• Regulatory Compliance: Users are responsible for compliance with regulations.

Disclaimer

This product is intended for laboratory research purposes only and is not for use in humans or animals.